Lite Strategy, Inc. Weighted Average Number of Shares, Restricted Stock
Lite Strategy, Inc. (LITS) reported Weighted Average Number of Shares, Restricted Stock of 0 shares for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesRestrictedStock · last filed 2020-09-09
- Lite Strategy, Inc. weighted average number of shares, restricted stock for the quarter ending 2019-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- Lite Strategy, Inc. weighted average number of shares, restricted stock for the quarter ending 2018-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- Lite Strategy, Inc. weighted average number of shares, restricted stock for the quarter ending 2018-03-31 was 397.00K shares, a 0.75% decline year-over-year.
- Lite Strategy, Inc. weighted average number of shares, restricted stock for the quarter ending 2017-12-31 was 400.00K shares, a 0.00% change year-over-year.
- Lite Strategy, Inc. weighted average number of shares, restricted stock for fiscal 2018 was 367.00K shares, a 2.91% decline from fiscal 2017.
- Lite Strategy, Inc. weighted average number of shares, restricted stock for fiscal 2017 was 378.00K shares, a 54.92% increase from fiscal 2016.
- Lite Strategy, Inc. weighted average number of shares, restricted stock for fiscal 2016 was 244.00K shares, a 119.82% increase from fiscal 2015.
- Lite Strategy, Inc. weighted average number of shares, restricted stock for fiscal 2015 was 111.00K shares.
| Period end | Weighted Average Number of Shares, Restricted Stock 3 month | Weighted Average Number of Shares, Restricted Stock 6 month | Weighted Average Number of Shares, Restricted Stock 9 month | Weighted Average Number of Shares, Restricted Stock 9 month as first filed | Weighted Average Number of Shares, Restricted Stock 12 month |
|---|---|---|---|---|---|
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-05-09 | 0.00 shares 10-Q · filed 2019-05-09 | |||
| 2018-12-31 | 0.00 shares 10-Q · filed 2019-02-07 | 0.00 shares 10-Q · filed 2019-02-07 | |||
| 2018-06-30 | 367.00K shares 10-K · filed 2020-09-09 | ||||
| 2018-03-31 | 397.00K shares 10-Q · filed 2019-05-09 | 399.00K shares 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | 400.00K shares 10-Q · filed 2019-02-07 | 400.00K shares 10-Q · filed 2019-02-07 | |||
| 2017-09-30 | 400.00K shares 10-Q · filed 2018-11-08 | ||||
| 2017-06-30 | 378.00K shares 10-K · filed 2019-08-28 | ||||
| 2017-03-31 | 400.00K shares 10-Q · filed 2018-05-09 | 370.00K shares 10-Q · filed 2018-05-09 | 370.32K shares 10-Q · filed 2017-05-04 | ||
| 2016-12-31 | 400.00K shares 10-Q · filed 2018-02-08 | 356.00K shares 10-Q · filed 2018-02-08 | |||
| 2016-09-30 | 311.00K shares 10-Q · filed 2017-11-08 | ||||
| 2016-06-30 | 244.00K shares 10-K · filed 2018-08-30 | ||||
| 2016-03-31 | 266.67K shares 10-Q · filed 2017-05-04 | 237.09K shares 10-Q · filed 2017-05-04 | |||
| 2015-06-30 | 111.00K shares 10-K · filed 2017-09-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |